Celltrion Healthcare Co., Ltd. Celltrion Healthcare Co., Ltd.

Celltrion Healthcare Co., Ltd.

091990

株式のランク #2142
Celltrion Healthcare Co., Ltd. is a global pharmaceutical company focused on... Celltrion Healthcare Co., Ltd. is a global pharmaceutical company focused on the development, manufacturing, and distribution of biosimilar and biological therapeutic agents for patients around the globe. Its product lineup includes Remsima, a monoclonal antibody biosimilar used to treat various inflammatory and autoimmune diseases such as rheumatoid arthritis, ankylosing spondylitis, ulcerative colitis, Crohn's disease in both adults and children, psoriasis, and psoriatic arthritis. Another significant offering, Truxima, targets conditions like lymphoma, chronic lymphocytic leukemia, Wegener's granulomatosis, microscopic polyangiitis, and rheumatoid arthritis. Herzuma is prescribed for metastatic breast cancer, early-stage breast cancer, and metastatic gastric cancer. Additionally, Remsima SC provides a treatment option for rheumatoid arthritis. Founded in 1999, the enterprise was initially known as Nexol, Inc. before rebranding to Celltrion Healthcare Co., Ltd. in March 2009. The firm's corporate headquarters are situated in Incheon, South Korea.
株価
$57.75
最終同期: 2024-01-11
時価総額
$9.42B
変化(1日)
-0.25%
変化(1年)
0.00%
国
KR
取引 Celltrion Healthcare Co., Ltd. (091990)

カテゴリー

Healthcare
Celltrion Healthcare Co., Ltd.(091990)の株式分割履歴
Celltrion Healthcare Co., Ltd.株(シンボル:091990)は合計で6回の株式分割を実施しました。
最新の株式分割はDec 28, 2022に行われました。
Dec 27, 2017より前に購入された091990株は、現在0.75210180542056091990株に相当します。
株式分割一覧
年 株式分割 分割比率 累積分割比率
2022-12-28 26:25 x1.04 x0.75210180542056
2021-12-29 51:52 x0.98076923076923 x0.72317481290438
2020-12-29 25:26 x0.96153846153846 x0.73735471119663
2019-12-27 21875:22542 x0.97041078874989 x0.76684889964449
2018-12-27 1020000:1136117 x0.89779485739585 x0.79023121809308
2017-12-27 60000:68167 x0.88019129490809 x0.88019129490809
類似企業または競合他社の株式分割
企業 株式分割の回数 累積分割比率 国
1 x2
US
0 -
US
1 x3
AU
0 -
NL
0 -
CH